The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.64 million shares were traded. NRIX stock price reached its highest trading level at $11.4 during the session, while it also had its lowest trading level at $11.14.
Ratios:
Our goal is to gain a better understanding of NRIX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.82 and its Current Ratio is at 6.82. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on March 17, 2025, initiated with a Market Perform rating and assigned the stock a target price of $16.
On December 10, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.BMO Capital Markets initiated its Outperform rating on December 06, 2024, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 02 ’25 when van Houte Hans sold 6,198 shares for $11.33 per share. The transaction valued at 70,243 led to the insider holds 33,724 shares of the business.
JOHANNES VAN HOUTE bought 6,198 shares of NRIX for $69,170 on May 02 ’25. On Apr 30 ’25, another insider, Hansen Gwenn, who serves as the Chief Scientific Officer of the company, sold 3,377 shares for $11.50 each. As a result, the insider received 38,841 and left with 61,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 860055744 and an Enterprise Value of 345266400. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.73 while its Price-to-Book (P/B) ratio in mrq is 1.92. Its current Enterprise Value per Revenue stands at 6.12 whereas that against EBITDA is -1.553.
Stock Price History:
The Beta on a monthly basis for NRIX is 2.15, which has changed by -0.4665718 over the last 52 weeks, in comparison to a change of 0.16260707 over the same period for the S&P500. Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $8.18. The 50-Day Moving Average of the stock is -1.56%, while the 200-Day Moving Average is calculated to be -31.84%.
Shares Statistics:
The stock has traded on average 888.24K shares per day over the past 3-months and 1230120 shares per day over the last 10 days, according to various share statistics. A total of 76.43M shares are outstanding, with a floating share count of 74.92M. Insiders hold about 2.00% of the company’s shares, while institutions hold 110.36% stake in the company. Shares short for NRIX as of 1749772800 were 14435008 with a Short Ratio of 15.84, compared to 1747267200 on 14116491. Therefore, it implies a Short% of Shares Outstanding of 14435008 and a Short% of Float of 22.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Nurix Therapeutics Inc (NRIX) is a result of the insights provided by 15.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.8, with high estimates of -$0.7 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$2.79 and -$3.56 for the fiscal current year, implying an average EPS of -$3.07. EPS for the following year is -$3.34, with 14.0 analysts recommending between -$1.62 and -$4.6.
Revenue Estimates
A total of 17 analysts have provided revenue estimates for NRIX’s current fiscal year. The highest revenue estimate was $89.28M, while the lowest revenue estimate was $18.5M, resulting in an average revenue estimate of $63.91M. In the same quarter a year ago, actual revenue was $54.55M
